{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T07:07:32Z","timestamp":1784185652955,"version":"3.55.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00216-026-06540-z","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T13:15:33Z","timestamp":1779282933000},"page":"4497-4514","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated data-independent acquisition and thermal proteome profiling for proteomic characterization of lamotrigine-treated MCF-7 cells"],"prefix":"10.1007","volume":"418","author":[{"given":"Annarita","family":"Giuliano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Gabriele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarosa","family":"Fava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Spadafora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catia","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Sisci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gaspari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"6540_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.semcancer.2020.02.010","volume":"72","author":"L Iacoviello","year":"2021","unstructured":"Iacoviello L, Bonaccio M, de Gaetano G, Donati MB. Epidemiology of breast cancer, a paradigm of the \u201ccommon soil\u201d hypothesis. Semin Cancer Biol. 2021;72:4\u201310. https:\/\/doi.org\/10.1016\/j.semcancer.2020.02.010.","journal-title":"Semin Cancer Biol"},{"key":"6540_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"key":"6540_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02108-4","author":"X Xiong","year":"2025","unstructured":"Xiong X, Zheng LW, Ding Y, Chen YF, Cai YW, Wang LP, et al. Breast cancer: pathogenesis and treatments. Signal Transduct Target Ther. 2025. https:\/\/doi.org\/10.1038\/s41392-024-02108-4.","journal-title":"Signal Transduct Target Ther"},{"key":"6540_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036905","volume":"103","author":"EI Obeagu","year":"2024","unstructured":"Obeagu EI, Obeagu GU. Breast cancer: a review of risk factors and diagnosis. Medicine (Baltimore). 2024;103:e36905.","journal-title":"Medicine (Baltimore)"},{"key":"6540_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093233","volume":"21","author":"K Bukowski","year":"2020","unstructured":"Bukowski K, Kciuk M, Kontek R. Mechanisms of multidrug resistance in cancer chemotherapy. Int J Mol Sci. 2020;21:3233.","journal-title":"Int J Mol Sci"},{"key":"6540_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155600","volume":"129","author":"J Zhang","year":"2024","unstructured":"Zhang J, Wu Y, Li Y, Li S, Liu J, Yang X, et al. Natural products and derivatives for breast cancer treatment: from drug discovery to molecular mechanism. Phytomedicine. 2024;129:155600. https:\/\/doi.org\/10.1016\/j.phymed.2024.155600.","journal-title":"Phytomedicine"},{"key":"6540_CR7","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.2174\/0929867325666171129215610","volume":"25","author":"S Olgen","year":"2018","unstructured":"Olgen S. Overview on anticancer drug design and development. Curr Med Chem. 2018;25:1704\u201319.","journal-title":"Curr Med Chem"},{"key":"6540_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21155262","volume":"21","author":"Q Li","year":"2020","unstructured":"Li Q, Kang C. Mechanisms of action for small molecules revealed by structural biology in drug discovery. Int J Mol Sci. 2020;21:1\u201318. https:\/\/doi.org\/10.3390\/ijms21155262.","journal-title":"Int J Mol Sci"},{"key":"6540_CR9","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/d41573-021-00190-9","volume":"21","author":"DG Brown","year":"2022","unstructured":"Brown DG, Wobst HJ, Kapoor A, Kenna LA, Southall N. Clinical development times for innovative drugs. Nat Rev Drug Discov. 2022;21:793\u20134. https:\/\/doi.org\/10.1038\/d41573-021-00190-9.","journal-title":"Nat Rev Drug Discov"},{"key":"6540_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2018","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2018;18:41\u201358. https:\/\/doi.org\/10.1038\/nrd.2018.168.","journal-title":"Nat Rev Drug Discov"},{"key":"6540_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/bmb\/ldaa045","volume":"137","author":"CH Schein","year":"2021","unstructured":"Schein CH. Repurposing approved drugs for cancer therapy. Br Med Bull. 2021;137:13\u201327.","journal-title":"Br Med Bull"},{"key":"6540_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm14082673","volume":"14","author":"N Tarawneh","year":"2025","unstructured":"Tarawneh N, Hussein SA, Abdalla S. Repurposing antiepileptic drugs for cancer: a promising therapeutic strategy. J Clin Med. 2025;14:1\u201326. https:\/\/doi.org\/10.3390\/jcm14082673.","journal-title":"J Clin Med"},{"key":"6540_CR13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2174\/1570159x17666191010094849","volume":"18","author":"F-C Kong","year":"2019","unstructured":"Kong F-C, Ma C-L, Zhong M-K. Epigenetic effects mediated by antiepileptic drugs and their potential application. Curr Neuropharmacol. 2019;18:153\u201366. https:\/\/doi.org\/10.2174\/1570159x17666191010094849.","journal-title":"Curr Neuropharmacol"},{"key":"6540_CR14","doi-asserted-by":"publisher","first-page":"7667","DOI":"10.1007\/s11033-023-08568-1","volume":"50","author":"M Aroosa","year":"2023","unstructured":"Aroosa M, Malik JA, Ahmed S, Bender O, Ahemad N, Anwar S. The evidence for repurposing anti-epileptic drugs to target cancer. Mol Biol Rep. 2023;50:7667\u201380. https:\/\/doi.org\/10.1007\/s11033-023-08568-1.","journal-title":"Mol Biol Rep"},{"key":"6540_CR15","doi-asserted-by":"publisher","unstructured":"Wilkowska A, Wiglusz MS, Jakuszkowiak-Wojten K, Cubala WJ. Ketamine and lamotrigine combination in psychopharmacology: systematic review. Cells. 2022;11:645. https:\/\/doi.org\/10.3390\/cells11040645.","DOI":"10.3390\/cells11040645"},{"key":"6540_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14184401","volume":"14","author":"M Pellegrino","year":"2022","unstructured":"Pellegrino M, Ricci E, Ceraldi R, Nigro A, Bonofiglio D, Lanzino M, et al. From HDAC to voltage-gated ion channels: what\u2019s next? The long road of antiepileptic drugs repositioning in cancer. Cancers (Basel). 2022;14:4401. https:\/\/doi.org\/10.3390\/cancers14184401.","journal-title":"Cancers (Basel)"},{"key":"6540_CR17","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1158\/1541-7786.MCR-17-0662","volume":"16","author":"M Pellegrino","year":"2018","unstructured":"Pellegrino M, Rizza P, Nigro A, Ceraldi R, Ricci E, Perrotta I, et al. FoxO3a mediates the inhibitory effects of the antiepileptic drug lamotrigine on breast cancer growth. Mol Cancer Res. 2018;16:923\u201334. https:\/\/doi.org\/10.1158\/1541-7786.MCR-17-0662.","journal-title":"Mol Cancer Res"},{"key":"6540_CR18","doi-asserted-by":"publisher","unstructured":"Frantzi M, Latosinska A, Mischak H. Proteomics in drug development: the dawn of a new era? Proteomics Clin Appl. 2019;13(2):e1800087. https:\/\/doi.org\/10.1002\/prca.201800087.","DOI":"10.1002\/prca.201800087"},{"key":"6540_CR19","doi-asserted-by":"publisher","first-page":"4728","DOI":"10.1021\/acs.analchem.4c06750","volume":"97","author":"CS Movassaghi","year":"2025","unstructured":"Movassaghi CS, Sun J, Jiang Y, Turner N, Chang V, Chung N, et al. Recent advances in mass spectrometry-based bottom-up proteomics. Anal Chem. 2025;97:4728\u201349. https:\/\/doi.org\/10.1021\/acs.analchem.4c06750.","journal-title":"Anal Chem"},{"key":"6540_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1529468","volume":"16","author":"H Cai","year":"2025","unstructured":"Cai H, Xing X, Su Y, Yang C. Innovative applications and future perspectives of chromatography-mass spectrometry in drug research. Front Pharmacol. 2025;16:1529468.","journal-title":"Front Pharmacol"},{"key":"6540_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pmic.201900276","volume":"20","author":"F Zhang","year":"2020","unstructured":"Zhang F, Ge W, Ruan G, Cai X, Guo T. Data-independent acquisition mass spectrometry-based proteomics and software tools: a glimpse in 2020. Proteomics. 2020;20:1\u201312. https:\/\/doi.org\/10.1002\/pmic.201900276.","journal-title":"Proteomics"},{"key":"6540_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2024.100800","volume":"23","author":"K Fr\u00f6hlich","year":"2024","unstructured":"Fr\u00f6hlich K, Fahrner M, Brombacher E, Seredynska A, Maldacker M, Kreutz C, et al. Data-independent acquisition: a milestone and prospect in clinical mass spectrometry\u2013based proteomics. Mol Cell Proteomics. 2024;23:100800. https:\/\/doi.org\/10.1016\/j.mcpro.2024.100800.","journal-title":"Mol Cell Proteomics"},{"key":"6540_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/emmm.202114850","volume":"15","author":"ME Due\u00f1as","year":"2023","unstructured":"Due\u00f1as ME, Peltier\u2010Heap RE, Leveridge M, Annan RS, B\u00fcttner FH, Trost M. Advances in high\u2010throughput mass spectrometry in drug discovery. EMBO Mol Med. 2023;15:1\u201315. https:\/\/doi.org\/10.15252\/emmm.202114850.","journal-title":"EMBO Mol Med"},{"key":"6540_CR24","doi-asserted-by":"publisher","unstructured":"Sridharan S, G\u00fcnthner I, Becher I, Savitski M, Bantscheff M. Target discovery using thermal proteome profiling. Mass Spectrom Chem Proteomics.\u00a0 2019;267\u2013291. https:\/\/doi.org\/10.1002\/9781118970195.ch11","DOI":"10.1002\/9781118970195.ch11"},{"key":"6540_CR25","doi-asserted-by":"publisher","unstructured":"Friman T. Mass spectrometry-based Cellular Thermal Shift Assay (CETSA\u00ae) for target deconvolution in phenotypic drug discovery. Bioorg Med Chem. 2020;28(1):115174. https:\/\/doi.org\/10.1016\/j.bmc.2019.115174.","DOI":"10.1016\/j.bmc.2019.115174"},{"key":"6540_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/science.1255784","volume":"346","author":"MM Savitski","year":"2014","unstructured":"Savitski MM, Reinhard FBM, Franken H, Werner T, Savitski MF, Eberhard D, et al. Tracking cancer drugs in living cells by thermal profiling of the proteome. Science. 2014;346:1255784.","journal-title":"Science"},{"key":"6540_CR27","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1074\/mcp.TIR118.001270","volume":"18","author":"TS Batth","year":"2019","unstructured":"Batth TS, Tollenaere MAX, R\u00fcther P, Gonzalez-Franquesa A, Prabhakar BS, Bekker-Jensen S, et al. Protein aggregation capture on microparticles enables multipurpose proteomics sample preparation. Mol Cell Proteomics. 2019;18:1027\u201335. https:\/\/doi.org\/10.1074\/mcp.TIR118.001270.","journal-title":"Mol Cell Proteomics"},{"key":"6540_CR28","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1021\/acs.jproteome.2c00513","volume":"22","author":"F Koopmans","year":"2023","unstructured":"Koopmans F, Li KW, Klaassen RV, Smit AB. MS-DAP platform for downstream data analysis of label-free proteomics uncovers optimal workflows in benchmark data sets and increased sensitivity in analysis of Alzheimer\u2019s biomarker data. J Proteome Res. 2023;22:374\u201386. https:\/\/doi.org\/10.1021\/acs.jproteome.2c00513.","journal-title":"J Proteome Res"},{"key":"6540_CR29","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.4c00417","author":"JH Hwang","year":"2024","unstructured":"Hwang JH, Lai A, Tung JP, Harkin DG, Flower RL, Pecheniuk NM. Proteomic characterization of transfusable blood components: fresh frozen plasma, cryoprecipitate, and derived extracellular vesicles via data-independent mass spectrometry. J Proteome Res. 2024. https:\/\/doi.org\/10.1021\/acs.jproteome.4c00417.","journal-title":"J Proteome Res"},{"key":"6540_CR30","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/NMETH.3652","volume":"12","author":"FBM Reinhard","year":"2015","unstructured":"Reinhard FBM, Eberhard D, Werner T, Franken H, Childs D, Doce C, et al. Thermal proteome profiling monitors ligand interactions with cellular membrane proteins. Nat Methods. 2015;12:1129\u201331. https:\/\/doi.org\/10.1038\/NMETH.3652.","journal-title":"Nat Methods"},{"key":"6540_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/jms.4669","author":"D Taverna","year":"2021","unstructured":"Taverna D, Gaspari M. A critical comparison of three MS-based approaches for quantitative proteomics analysis. J Mass Spectrom. 2021. https:\/\/doi.org\/10.1002\/jms.4669.","journal-title":"J Mass Spectrom"},{"key":"6540_CR32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1074\/mcp.RA119.001714","volume":"19","author":"K Barkovits","year":"2020","unstructured":"Barkovits K, Pacharra S, Pfeiffer K, Steinbach S, Eisenacher M, Marcus K, et al. Reproducibility, specificity and accuracy of relative quantification using spectral librarybased data-independent acquisition. Mol Cell Proteomics. 2020;19:181\u201397. https:\/\/doi.org\/10.1074\/mcp.RA119.001714.","journal-title":"Mol Cell Proteomics"},{"key":"6540_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2021.641931","volume":"11","author":"M Niu","year":"2021","unstructured":"Niu M, Shan M, Liu Y, Song Y, Han JG, Sun S, et al. DCTPP1, an oncogene regulated by miR-378a-3p, promotes proliferation of breast cancer via DNA repair signaling pathway. Front Oncol. 2021;11:1\u201312. https:\/\/doi.org\/10.3389\/fonc.2021.641931.","journal-title":"Front Oncol"},{"key":"6540_CR34","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000024827","volume":"100","author":"H Li","year":"2021","unstructured":"Li H, Cao Y, Ma J, Luo L, Ma B. Expression and prognosis analysis of GINS subunits in human breast cancer. Medicine (Baltimore). 2021;100:E24827. https:\/\/doi.org\/10.1097\/MD.0000000000024827.","journal-title":"Medicine (Baltimore)"},{"key":"6540_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05513-z","volume":"22","author":"D Mo","year":"2024","unstructured":"Mo D, Tang X, Ma Y, Chen D, Xu W, Jiang N, et al. tRNA-derived fragment 3\u2032tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer. J Transl Med. 2024;22:05513-z. https:\/\/doi.org\/10.1186\/s12967-024-05513-z.","journal-title":"J Transl Med"},{"key":"6540_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2024.195050","volume":"1867","author":"M Ad\u00e1mik","year":"2024","unstructured":"Ad\u00e1mik M, Sold\u00e1nov\u00e1 Z, Drot\u00e1rov\u00e1 M, Bre\u010dkov\u00e1 K, Petr M, Helma R, et al. Human ARMC6 binds in vitro to both cancer genes and telomeric RNA, favoring g-quadruplex structure recognition. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 2024;1867:195050. https:\/\/doi.org\/10.1016\/j.bbagrm.2024.195050.","journal-title":"Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms"},{"key":"6540_CR37","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.2147\/CMAR.S479151","volume":"16","author":"M Izdebska","year":"2024","unstructured":"Izdebska M, Arendt W, Ha\u0142as-Wi\u015bniewska M, Zakrzewski P, Lenartowski R, Lenartowska M. The actin motor protein Myosin 6 contributes to cell migration and expression of GIPC1 and septins in breast cancer cells. Cancer Manag Res. 2024;16:1445\u201362. https:\/\/doi.org\/10.2147\/CMAR.S479151.","journal-title":"Cancer Manag Res"},{"key":"6540_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcp.31481","volume":"240","author":"B Zhao","year":"2025","unstructured":"Zhao B, Ye DM, Li S, Zhang Y, Zheng Y, Kang J, et al. FMNL3 promotes migration and invasion of breast cancer cells via inhibiting Rad23B-induced ubiquitination of Twist1. J Cell Physiol. 2025;240:1\u201315. https:\/\/doi.org\/10.1002\/jcp.31481.","journal-title":"J Cell Physiol"},{"key":"6540_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-024-01842-5","volume":"26","author":"N Raghuram","year":"2024","unstructured":"Raghuram N, Temel EI, Kawamata T, Kozma KJ, Loch AJ, Wang W, et al. Elevated expression of wildtype RhoC promotes ErbB2- and Pik3ca-induced mammary tumor formation. Breast Cancer Res. 2024;26:1\u201312. https:\/\/doi.org\/10.1186\/s13058-024-01842-5.","journal-title":"Breast Cancer Res"},{"key":"6540_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/genes14101879","author":"M Ngubo","year":"2023","unstructured":"Ngubo M, Moradi F, Ito CY, Stanford WL. Tissue-specific tumour suppressor and oncogenic activities of the Polycomb-like protein MTF2. Genes. 2023. https:\/\/doi.org\/10.3390\/genes14101879.","journal-title":"Genes"},{"key":"6540_CR41","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/cac2.12479","volume":"43","author":"W Liu","year":"2023","unstructured":"Liu W, Zeng Y, Hao X, Wang X, Liu J, Gao T, et al. JARID2 coordinates with the NuRD complex to facilitate breast tumorigenesis through response to adipocyte-derived leptin. Cancer Commun. 2023;43:1117\u201342. https:\/\/doi.org\/10.1002\/cac2.12479.","journal-title":"Cancer Commun"},{"key":"6540_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2023.147174","volume":"857","author":"Y Ouyang","year":"2023","unstructured":"Ouyang Y, Lu W, Wang Y, Wang B, Li F, Li X, et al. Integrated analysis of mRNA and extrachromosomal circular DNA profiles to identify the potential mRNA biomarkers in breast cancer. Gene. 2023;857:147174. https:\/\/doi.org\/10.1016\/j.gene.2023.147174.","journal-title":"Gene"},{"key":"6540_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BSR20200869","volume":"41","author":"Z Lin","year":"2021","unstructured":"Lin Z, Peng R, Sun Y, Zhang L, Zhang Z. Identification of ribosomal protein family in triple-negative breast cancer by bioinformatics analysis. Biosci Rep. 2021;41:1\u201312. https:\/\/doi.org\/10.1042\/BSR20200869.","journal-title":"Biosci Rep"},{"key":"6540_CR44","doi-asserted-by":"publisher","first-page":"30237","DOI":"10.1074\/jbc.M114.596155","volume":"289","author":"PW Chen","year":"2014","unstructured":"Chen PW, Luo R, Jian X, Randazzo PA. The Arf6 GTPase-activating proteins ARAP2 and ACAP1 define distinct endosomal compartments that regulate integrin \u03b15\u03b2S1 traffic. J Biol Chem. 2014;289:30237\u201348. https:\/\/doi.org\/10.1074\/jbc.M114.596155.","journal-title":"J Biol Chem"},{"key":"6540_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14235951","volume":"14","author":"Q Yi","year":"2022","unstructured":"Yi Q, Pu Y, Chao F, Bian P, Lv L. ACAP1 deficiency predicts inferior immunotherapy response in solid tumors. Cancers (Basel). 2022;14:5951. https:\/\/doi.org\/10.3390\/cancers14235951.","journal-title":"Cancers (Basel)"},{"key":"6540_CR46","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/nprot.2015.101","volume":"10","author":"H Franken","year":"2015","unstructured":"Franken H, Mathieson T, Childs D, Sweetman GMA, Werner T, T\u00f6gel I, et al. Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry. Nat Protoc. 2015;10:1567\u201393. https:\/\/doi.org\/10.1038\/nprot.2015.101.","journal-title":"Nat Protoc"},{"key":"6540_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.202200435","author":"R Noberini","year":"2023","unstructured":"Noberini R, Bonaldi T. Proteomics contributions to epigenetic drug discovery. Proteomics. 2023. https:\/\/doi.org\/10.1002\/pmic.202200435.","journal-title":"Proteomics"},{"key":"6540_CR48","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.3892\/ijo.2016.3387","volume":"48","author":"KM Goudarzi","year":"2016","unstructured":"Goudarzi KM, Lindstr\u00f6m MS. Role of ribosomal protein mutations in tumor development (Review). Int J Oncol. 2016;48:1313\u201324. https:\/\/doi.org\/10.3892\/ijo.2016.3387.","journal-title":"Int J Oncol"},{"key":"6540_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1168-7","volume":"9","author":"X Xiong","year":"2018","unstructured":"Xiong X, Liu X, Li H, He H, Sun Y, Zhao Y. Ribosomal protein S27-like regulates autophagy via the \u03b2-TrCP-DEPTOR-mTORC1 axis. Cell Death Dis. 2018;9:1168-7. https:\/\/doi.org\/10.1038\/s41419-018-1168-7.","journal-title":"Cell Death Dis"},{"key":"6540_CR50","doi-asserted-by":"publisher","first-page":"889","DOI":"10.17219\/acem\/147271","volume":"31","author":"J Wan","year":"2022","unstructured":"Wan J, Lv J, Wang C, Zhang L. RPS27 selectively regulates the expression and alternative splicing of inflammatory and immune response genes in thyroid cancer cells. Adv Clin Exp Med. 2022;31:889\u2013901. https:\/\/doi.org\/10.17219\/acem\/147271.","journal-title":"Adv Clin Exp Med"},{"key":"6540_CR51","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1158\/0008-5472.CAN-24-1204","volume":"85","author":"S Tau","year":"2025","unstructured":"Tau S, Chamberlin MD, Yang H, Marotti JD, Muskus PC, Roberts AM, et al. Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy\u2013tolerant persister cells in ER+ breast cancer. Cancer Res. 2025;85:1145\u201361.","journal-title":"Cancer Res"},{"key":"6540_CR52","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","volume":"23","author":"M Tufail","year":"2024","unstructured":"Tufail M, Jiang C-H, Li N. Altered metabolism in cancer: insights into energy pathways and therapeutic targets. Mol Cancer. 2024;23:203.","journal-title":"Mol Cancer"},{"key":"6540_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-025-00694-x","author":"V Marchio","year":"2025","unstructured":"Marchio V, Augimeri G, Morelli C, Vivacqua A, Giordano C, Catalano S, et al. Omega-3 fatty acids: molecular weapons against chemoresistance in breast cancer. Cell Mol Biol Lett. 2025. https:\/\/doi.org\/10.1186\/s11658-025-00694-x.","journal-title":"Cell Mol Biol Lett"},{"key":"6540_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/cells8020089","author":"N Gandhi","year":"2019","unstructured":"Gandhi N, Das GM. Metabolic reprogramming in breast cancer and its therapeutic implications. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8020089.","journal-title":"Cells"},{"key":"6540_CR55","doi-asserted-by":"publisher","first-page":"8003","DOI":"10.1111\/febs.16218","volume":"289","author":"M Sollazzo","year":"2022","unstructured":"Sollazzo M, De Luise M, Lemma S, Bressi L, Iorio M, Miglietta S, et al. Respiratory Complex I dysfunction in cancer: from a maze of cellular adaptive responses to potential therapeutic strategies. FEBS J. 2022;289:8003\u201319. https:\/\/doi.org\/10.1111\/febs.16218.","journal-title":"FEBS J"},{"key":"6540_CR56","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/stem.578","volume":"29","author":"Z Zhang","year":"2011","unstructured":"Zhang Z, Jones A, Sun C-W, Li C, Chang C-W, Joo H-Y, et al. PRC2 complexes with JARID2, MTF2, and esPRC2p48 in ES cells to modulate ES cell pluripotency and somatic cell reprogramming. Stem Cells. 2011;29:229\u201340. https:\/\/doi.org\/10.1002\/stem.578.","journal-title":"Stem Cells"},{"key":"6540_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01886-1","author":"M He","year":"2024","unstructured":"He M, Zhou X, Wang X. Glycosylation: mechanisms, biological functions and clinical implications. Signal Transduct Target Ther. 2024. https:\/\/doi.org\/10.1038\/s41392-024-01886-1.","journal-title":"Signal Transduct Target Ther"},{"key":"6540_CR58","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.7150\/thno.81760","volume":"13","author":"T \u010caval","year":"2023","unstructured":"\u010caval T, Alisson-Silva F, Schwarz F. Roles of glycosylation at the cancer cell surface: opportunities for large scale glycoproteomics. Theranostics. 2023;13:2605\u201315. https:\/\/doi.org\/10.7150\/thno.81760.","journal-title":"Theranostics"},{"key":"6540_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11033-024-09645-9","volume":"51","author":"A Gadwal","year":"2024","unstructured":"Gadwal A, Purohit P, Khokhar M, Vishnoi JR, Pareek P, Choudhary R, et al. GALNT14 in association with GDF-15 promotes stemness and drug resistance through \u03b2-catenin signalling pathway in breast cancer. Mol Biol Rep. 2024;51:1\u201312. https:\/\/doi.org\/10.1007\/s11033-024-09645-9.","journal-title":"Mol Biol Rep"},{"key":"6540_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-022-05419-y","volume":"13","author":"YD Chu","year":"2022","unstructured":"Chu YD, Fan TC, Lai MW, Yeh CT. GALNT14-mediated O-glycosylation on PHB2 serine-161 enhances cell growth, migration and drug resistance by activating IGF1R cascade in hepatoma cells. Cell Death Dis. 2022;13:1\u201313. https:\/\/doi.org\/10.1038\/s41419-022-05419-y.","journal-title":"Cell Death Dis"},{"key":"6540_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2023.100560","volume":"22","author":"K Yin","year":"2023","unstructured":"Yin K. Investigation of cellular response to the HSP90 inhibition in human cells through thermal proteome profiling. Mol Cell Proteomics. 2023;22:100560. https:\/\/doi.org\/10.1016\/j.mcpro.2023.100560.","journal-title":"Mol Cell Proteomics"},{"key":"6540_CR62","unstructured":"Axelsson H, Almqvist H, Seashore-Ludlow B, Lundb\u00e4ck T. Screening for target engagement using the cellular thermal shift assay-CETSA. Assay Guidance Manual [Internet]. 2016. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK424743\/."},{"key":"6540_CR63","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/2472555219877183","volume":"25","author":"MJ Henderson","year":"2020","unstructured":"Henderson MJ, Holbert MA, Simeonov A, Kallal LA. High-throughput cellular thermal shift assays in research and drug discovery. SLAS Discov. 2020;25:137\u201347. https:\/\/doi.org\/10.1177\/2472555219877183.","journal-title":"SLAS Discov"},{"key":"6540_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154862","volume":"116","author":"Y Tu","year":"2023","unstructured":"Tu Y, Tan L, Tao H, Li Y, Liu H. CETSA and thermal proteome profiling strategies for target identification and drug discovery of natural products. Phytomedicine. 2023;116:154862. https:\/\/doi.org\/10.1016\/j.phymed.2023.154862.","journal-title":"Phytomedicine"},{"key":"6540_CR65","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.eplepsyres.2017.07.003","volume":"136","author":"J Finsterer","year":"2017","unstructured":"Finsterer J, Scorza FA. Review article e ff ects of antiepileptic drugs on mitochondrial functions, morphology, kinetics, biogenesis, and survival. Epilepsy Res. 2017;136:5\u201311. https:\/\/doi.org\/10.1016\/j.eplepsyres.2017.07.003.","journal-title":"Epilepsy Res"},{"key":"6540_CR66","doi-asserted-by":"publisher","unstructured":"Modulation F. Acute valproate exposure induces mitochondrial biogenesis and autophagy with FOXO3a modulation in SH-SY5Y cells. Cells. 2021;10(8):1954. https:\/\/doi.org\/10.3390\/cells10081954.","DOI":"10.3390\/cells10081954"},{"key":"6540_CR67","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.tox.2015.03.001","volume":"331","author":"T Komulainen","year":"2015","unstructured":"Komulainen T, Lodge T, Hinttala R, Bolszak M, Pietil\u00e4 M, Koivunen P, et al. Sodium valproate induces mitochondrial respiration dysfunction in HepG2 in vitro cell model. Toxicology. 2015;331:47\u201356. https:\/\/doi.org\/10.1016\/j.tox.2015.03.001.","journal-title":"Toxicology"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-026-06540-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00216-026-06540-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-026-06540-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:56:08Z","timestamp":1784184968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00216-026-06540-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":67,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["6540"],"URL":"https:\/\/doi.org\/10.1007\/s00216-026-06540-z","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"19 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier\u00a0PXD070795.","order":2,"name":"Ethics","label":"Data requirements","group":{"name":"EthicsHeading","label":"Declarations"}}]}}